Skip to main content
. Author manuscript; available in PMC: 2013 Sep 1.
Published in final edited form as: Psychopharmacology (Berl). 2012 Apr 4;223(1):107–116. doi: 10.1007/s00213-012-2698-9

Table 1.

Overview of treatment design.

Study Days Week 1 Week 2 Week 3 Week 4 Week 5
Phase Baseline Drug Manipulation Standard
Visits #1 #2 #3 #4
Varenicline group V V V V
Placebo group P P P V

Note: TQD = Target Quit Date; V = varenicline; P = placebo;